TITLE

Low Molecular Weight Dextran Infusions in Systemic Sclerosis with Raynaud's Phenomenon: A Report of Nine Cases

AUTHOR(S)
Lane, Peter
PUB. DATE
December 1970
SOURCE
British Medical Journal;12/12/1970, Vol. 4 Issue 5736, p657
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64098685

 

Related Articles

  • Cocaine-Induced Raynaud’s Phenomenon and Ischaemic Finger Necrosis. Balbir-Gurman, A.; Braun-Moscovici, Y.; Nahir, A. M. // Clinical Rheumatology;Sep2001, Vol. 20 Issue 5, p376 

    : A 37-year-old man with ischaemic finger necrosis and recent-onset Raynaud’s phenomenon associated with cocaine abuse is reported. Initial therapy with systemic vasodilators, low-molecular-weight heparin and aspirin failed. Resolution of the ischaemia and ulcer healing was rapidly...

  • ACUTE ERGOT POISONING. London, M.; Magora, F.; Rogel, S.; Romanoff, H. // Angiology;Oct1970, Vol. 21 Issue 9, p565 

    A case of severe vascular complications in a young woman has been reported, after a short, per oral administration of ergotamine tartrate. The use of epidural anesthesia, stellate ganglion blocks and the infusion of low molecular weight dextran resulted in the complete recovery of the patient.

  • Pathophysiology of Raynaud's phenomenon.  // British Medical Journal;10/18/1980, Vol. 281 Issue 6247, p1027 

    Examines the pathophysiology of Raynaud's phenomenon. Clinical manifestations of the disease; Relationship between Raynaud's disease and systemic multiple sclerosis; Drug for interventions.

  • Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study. Rademaker, M.; Cooke, E.D.; Almond, N.E.; Beacham, J.A.; Smith, R.E.; Mant, T.G.K.; Kirby, J.D. // BMJ: British Medical Journal (International Edition);3/4/89, Vol. 298 Issue 6673, p561 

    Compares the long term effects of intravenous infusions of iloprost with oral nifedipine in patients with Raynaud's phenomenon associated with systemic sclerosis. Selection of population; Enumeration of variables used as bases of comparison; Benefits of both treatment.

  • Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis. Arefiev, Kait; Fiorentino, David F.; Chung, Lorinda // International Journal of Rheumatology;2011, Vol. 2011, p1 

    Systemic sclerosis is a connective tissue disease characterized by fibrosis of the skin, internal organs, and widespread vasculopathy. Raynaud's phenomenon and digital ulcers are vascular manifestations of this disease and cause significant morbidity. Current treatments are only moderately...

  • Systemic sclerosis in old age.  // British Medical Journal;11/24/1979, Vol. 2 Issue 6201, p1313 

    Examines the occurrence of systemic sclerosis in elderly patients. Effect of Raynaud's phenomenon on the hands of patients with systemic sclerosis; Diagnosis of systemic sclerosis; Symptoms of systemic sclerosis.

  • Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Wigley, Fredrick M.; Wise, Robert A.; Seibold, James R.; McCloskey, Deborah A.; Kujala, Gregory; Medsger Jr., Thomas A.; Steen, Virginia D.; Varga, John; Jimenez, Sergio; Mayes, Maureen; Clements, Philip J.; Weiner, Steven R.; Porter, John; Ellman, Michael; Wise, Christopher; Kaufman, Lee D.; Williams, John; Dole, William; Wigley, F M; Wise, R A // Annals of Internal Medicine;2/1/94, Vol. 120 Issue 3, p199 

    Objective: To evaluate the efficacy and safety of iloprost, a prostacyclin analog, administered intravenously in patients with Raynaud phenomenon secondary to systemic sclerosis.Design: Multicenter, randomized, parallel placebo-controlled, double-blind...

  • Stenting a downstream, distal endarterectomy. Sherman, Roger W.; H.D.B. // Cortlandt Forum;6/25/95, Vol. 8 Issue 6, p73 

    Reports on the use of stents in distal endarterectomy. Opening of the anastomotic site; Use of postoperative heparin or low-molecular-weight dextran.

  • Artifactual Hypoglycaemia in Systemic Sclerosis and Raynaud’s Phenomenon: A Clinical Case Report and Short Review. Bishay, R. H.; Suryawanshi, A. // Case Reports in Endocrinology;12/28/2016, p1 

    Background. Artifactual hypoglycaemia, defined as a discrepancy between glucometer (capillary) and plasma glucose levels, may lead to overtreatment and costly investigations. It is not infrequently observed in patients with Raynaud’s phenomenon due to vascular capillary distortion, yet...

  • Iloprost.  // Reactions Weekly;1/5/2013, Issue 1433, p25 

    The article describes the case of a 40-year-old man with diffuse cutaneous systemic sclerosis who developed a paradoxical reaction of Raynaud phenomenon while receiving treatment with iloprost.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics